Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Pfizer Launches App for Patients with Depression

XTALKS VITALS NEWS

App

Pfizer’s app – known as Moodivator – helps patients track their daily moods, and share goals with their healthcare provider to help them make progress in their treatment.

Share this!

December 20, 2016 | by Sarah Hand, M.Sc.

Drugmakers are gradually breaking into the popular health app space, with big pharmaceutical company, Pfizer, launching its mood tracking app for people with depression. While the app is linked to Pfizer’s depression medication, Pristiq, it is not a medication adherence tool like Eli Lilly’s Trulicity app.

Pfizer’s app – known as Moodivator – helps patients track their daily moods, and share goals with their healthcare provider to help them make progress in their treatment. According to app analytics platform Sensor Tower, the Moodivator app has been downloaded less than 5,000 times since its launch in September.

“Moodivator is designed to motivate patients and help complement their treatment by allowing patients to track their mood, set goals, and establish routines that can help support them in their daily life,” said Julie Ferguson, senior manager of communications for Pfizer. “This is important because even seemingly small tasks can feel difficult for people with depression. Patients receive encouraging inspirational messages in the app to help motivate them along the way.”



While the app does contain information about Pfizer’s Pristiq, patients do not need to be prescribed the depression drug in order to use the app. According to Ferguson, the app is helpful for patients who are unable to attend in-person therapy sessions but need a way to manage and keep track of the progress of their depression.

“Advances in technology are now offering patients new tools to help them as they manage their depression,” said Ferguson. “We developed the Moodivator app in consultation with psychiatrists to help complement a patient’s treatment by providing ongoing motivation in a simple, efficient, and portable way for those living with depression.”

Pfizer also offers patient support to users of Pristiq through a program known as the Wind Up. This is a service which sends motivational messages as well as prescription refill reminders to patients via email, regular mail and text messages.


Keywords: Pfizer, Depression, Health App


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Use of Testosterone Treatments Boosted by DTC Ad Campaigns

March 24, 2017 - Those with a stake in the pharmaceutical industry often question the effectiveness of direct-to-consumer (DTC) advertising, and whether it truly influences consumers to talk to their doctors about medical conditions and perhaps even ask for drugs by name.

Featured In: Pharmaceutical Marketing News


FDA Approves New Drug for Parkinson’s Disease

March 23, 2017 - Newron Pharmaceuticals’ Xadago (safinamide) has been approved by the US Food and Drug Administration (FDA) as an add-on medication for patients with Parkinson’s disease.

Featured In: Clinical Trials News, Life Science News, Pharmaceutical News


Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor

March 23, 2017 - Most US patients hoping to get their PCSK9 inhibitor medications covered by their prescription drug plan are being denied, according to two new studied conducted by Amgen.

Featured In: Biotech News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.